FDA-Approved MEK1/2 Inhibitor, Trametinib, Protects Mice from Cisplatin and Noise-Induced Hearing Loss
Richard D. Lutze(Creighton University), Tal Teitz(St. Jude Children's Research Hospital)
Cited by 0
Related Papers
CDK2 inhibitors as candidate therapeutics for cisplatin- and noise-induced hearing loss
|The Journal of Experimental Medicine|2018|102
Trametinib, a MEK1/2 Inhibitor, Protects Mice from Cisplatin- and Noise-Induced Hearing Loss
|Pharmaceuticals|2024|3
Oseltamivir (Tamiflu), a Commonly Prescribed Antiviral Drug, Mitigates Hearing Loss in Mice
|bioRxiv (Cold Spring Harbor Laboratory)|2024|1